- Qualification: DM Clinical Haematology (NRS Medical College, Kolkata); postdoctoral fellowship and FACT-accredited BMT training, Tata Medical Center, Kolkata
- Current roles: Head, Bone Marrow Transplant & CAR-T Program, Bhagwan Mahaveer Cancer Hospital & Research Centre (BMCHRC), Jaipur; Director, Jaipur Hematology Centre
- Experience: Over a decade of post-DM clinical practice in hematology, bone marrow transplant and CAR-T cell therapy, including the first CAR-T cell therapy in Rajasthan
- Registration: Rajasthan Medical Council RMC-25451/23661
- Where to see him: Jaipur Hematology Centre consultations Monday to Saturday, 5:00 PM to 7:30 PM (closed Sunday). Dr Shekhawat is at Bhagwan Mahaveer Cancer Hospital & Research Centre (BMCHRC), Jaipur, from 9:00 AM to 5:00 PM on working days.
Dr Prakash Singh Shekhawat is a hematologist, hemato-oncologist and bone marrow transplant (BMT) specialist in Jaipur with a DM in Clinical Haematology and over a decade of post-DM clinical experience. He is Head of the Bone Marrow Transplant & CAR-T Program at Bhagwan Mahaveer Cancer Hospital & Research Centre (BMCHRC), Jaipur, and Director of Jaipur Hematology Centre.
His work includes autologous and allogeneic bone marrow transplant (including matched sibling and haploidentical family-donor transplants) and CAR-T cell therapy. In December 2024, he performed the first CAR-T cell therapy in Rajasthan, at BMCHRC, Jaipur.
He trained at NRS Medical College, Kolkata (DM Clinical Haematology) and Tata Medical Center, Kolkata (postdoctoral fellowship and FACT-accredited BMT training). He publishes in hematology, oncology, BMT and CAR-T, contributes to professional guidelines, and speaks at national conferences including Hematocon, BeSHCON and Best of ASH. His work also includes protocol development, clinical trials, teaching and public awareness about blood disorders.
Vision and approach to care
Dr Shekhawat aims to provide hematology, BMT and CAR-T care that is careful, timely and clearly explained, for patients of all ages. His aim is that every patient, child or adult, receives an accurate diagnosis and a treatment plan discussed in plain language, in line with current medical evidence.
He works through clear communication and shared decision-making, helping patients and families understand the diagnosis, treatment choices, possible risks and follow-up. Care is planned with a multidisciplinary hospital team when it is needed.
Conditions treated
He offers diagnosis and management of blood disorders, including anemia, thalassemia, sickle cell disease, aplastic anemia, bleeding disorders, ITP, hemophilia, low platelet disorders, DVT and unusual clots, ALPS, primary immune deficiencies, acute leukemias, CML, CLL, lymphomas, multiple myeloma, MDS, PNH, eosinophilia, spleen and lymph node enlargement. Treatment may include medicines, chemotherapy, immunotherapy, bone marrow transplantation and CAR-T cell therapy, depending on the condition.
Roles and work
- Performed the first CAR-T cell therapy in Rajasthan, at BMCHRC, Jaipur, in December 2024.
- Head of the Bone Marrow Transplant & CAR-T Program at BMCHRC, Jaipur. He has also set up bone marrow transplant services at NIMS and BMCHRC, Jaipur.
- Principal Investigator and Co-Investigator for national and industry-sponsored clinical trials.
- Contributor to national hematology consensus guidelines and professional recommendations.
- Faculty and invited speaker at national medical conferences, including Hematocon, BeSHCON and Best of ASH.
Videos
Publications and teaching
He has published research and reviews in hematology, oncology, BMT and CAR-T, including work on real-world CAR-T outcomes, transplant cost-effectiveness, APL management, neutropenic sepsis and telemedicine. He also teaches and speaks at national conferences.